secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2023-02-10T23:59:59+00:00
Accession:  0001654954-23-001582
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZIVO BIOSCIENCE announces study results; full details not in filing excerpt
---------------------------------------------------------------------------

- Press release dated February 10, 2023 issued regarding results of a recent study.
- Complete text of Exhibit 99.1 is not included in the provided filing excerpt.
- No specific study outcomes, numbers, or conclusions are extractable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423001582/0001654954-23-001582-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495423001582/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-001582

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer